Starting HPV vaccination at 9–14 years of age (except people who are immunocompromised)
2
0, 6–12 months
The recommended age for HPV vaccination is 12–13 years, but people can receive vaccines from 9 years of age.
If a person has received 2 doses of HPV vaccine with an interval of <5 months between dose 1 and dose 2, they need a 3rd dose at least 12 weeks after the 2nd dose. Ensure that the minimum intervals for 3 doses are met.
If the 2nd dose is received <6 months but ≥5 months after the 1st dose, a 3rd dose is not required; clinical trial data support this interval still being sufficiently immunogenic.
Starting HPV vaccination at ≥15 years of age
3
0, 2, 6 months
A 3-dose schedule of 0, 1 and 6 months for 2vHPV (2-valent HPV) vaccine is acceptable.
People who are immunocompromised at any age (excluding those with asplenia or hyposplenia)
3
0, 2, 6 months
A 3-dose schedule of 0, 1 and 6 months for 2vHPV vaccine is acceptable.
